Results 231 to 240 of about 580,532 (393)
Arterial mechanical properties in dilated cardiomyopathy. Aging and the response to nitroprusside. [PDF]
John D. Carroll+4 more
openalex +1 more source
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung+8 more
wiley +1 more source
Pulmonary artery banding for dilated cardiomyopathy in children: report of 3 cases. [PDF]
Meng L+6 more
europepmc +1 more source
Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. [PDF]
Massimo Volpe+9 more
openalex +1 more source
Abstract Aims In heart failure patients, altered myocardial electrical fields linked to oedema may impair left ventricular function. While short‐term use of implanted microcurrent generators (C‐MIC) has shown promise, long‐term effects remain unclear.
Dragana B. Kosevic+14 more
wiley +1 more source
Reversible dilated cardiomyopathy due to thyrotoxicosis
E.Joseph Bauerlein+2 more
openalex +1 more source
Atrial TR as more favourable prognosis except in advanced patients. Abstract Background and Aims Although the classification of secondary tricuspid regurgitation (STR) by atrial or ventricular aetiology (A‐STR or V‐STR) carries prognostic importance, the confounding effects of New York Heart Association (NYHA) class have not yet been elucidated.
Corentin Bourg+9 more
wiley +1 more source